BIOPORTO DIAGNOSTICS A/S: Financial statements 2023
CVR: 18645882
Source: annual report 2023, Danish Business Authority
01/01/2023 – 31/12/2023
BIOPORTO DIAGNOSTICS A/S (CVR 18645882) has filed annual accounts for 2023. In 2023, the company reported revenue of DKK 30,958,179 and a net result of DKK -104,752,919 compared with DKK -81,772,343 the year before. That is an increase of 6.9% compared with the year before. The profit margin was -338.4%. Equity in the 2023 report amounted to DKK -645,274,240. The company had 21 employees in the financial year.
- Revenue
- DKK 30,958,179
- Gross Profit
- DKK -4,436,032
- Profit/Loss
- DKK -104,752,919
- Equity
- DKK -645,274,240
- Total Assets
- DKK 14,395,689
- Employees
- 21
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2023 | 31M | -4.4M | -104.8M | -645.3M | 21 |
| 2022 | 29M | -13.2M | -81.8M | -540.5M | 20 |
| 2021 | 24.3M | -15.2M | -54.1M | -458.7M | 15 |
| 2020 | 23.2M | -10.6M | -42.6M | -404.6M | 16 |
| 2019 | 26.6M | -6.9M | -67.3M | -362M | 17 |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record, straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2023
As of December 5, 2023, Nis Glavind Kruse has joined the board of directors of BIOPORTO DIAGNOSTICS A/S.
As of December 5, 2023, Peter Mørch Eriksen has joined the board of directors of BIOPORTO DIAGNOSTICS A/S.
As of December 4, 2023, Jan Leth Christensen has left the board of directors of BIOPORTO DIAGNOSTICS A/S.
As of December 4, 2023, Peter Mørch Eriksen has left the board of directors of BIOPORTO DIAGNOSTICS A/S.
As of October 15, 2023, Jan Leth Christensen has joined the board of directors of BIOPORTO DIAGNOSTICS A/S.
As of October 15, 2023, Neil Allan Goldman has left the board of directors of BIOPORTO DIAGNOSTICS A/S.
As of October 14, 2023, Jan Leth Christensen has left the board of directors of BIOPORTO DIAGNOSTICS A/S.
BIOPORTO DIAGNOSTICS A/S has published its annual report for 2022. Revenue came to DKK 28,969,229, and the net result was DKK -81,772,343.
As of January 2, 2023, DELOITTE STATSAUTORISERET REVISIONSPARTNERSELSKAB has been appointed auditor of BIOPORTO DIAGNOSTICS A/S.
As of January 2, 2023, PRICEWATERHOUSECOOPERS STATSAUTORISERET REVISIONSPARTNERSELSKAB has stepped down as auditor of BIOPORTO DIAGNOSTICS A/S.
About BIOPORTO DIAGNOSTICS A/S
BIOPORTO DIAGNOSTICS A/S is a Danish company of the type Aktieselskab based in Hellerup, founded in 1995. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company was previously named ANTIBODYSHOP A/S and IMMUNOLEX ApS. The management consists of Carsten Buhl. The board consists of Gry Louise Husby Larsen (chair), Carsten Buhl and Klaus Juhl Wulff. The company is owned by BIOPORTO A/S. The company has 28 employees (2026). In 2025, the company reported revenue of DKK 40,286,970 and a net result of DKK -81,398,096 compared with DKK -110,908,377 the year before. Equity in the 2025 report amounted to DKK -837,580,713.